Catalyst Funds Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.99M Buy
7,664
+5,590
+270% +$2.36M 0.17% 140
2026
Q1
$982K Buy
2,074
+154
+8% +$77.5K 0.17% 155
2025
Q4
$896K Sell
1,920
-3,680
-66% -$1.71M 0.21% 122
2025
Q3
$2.39M Buy
5,600
+3,900
+229% +$1.51M 0.36% 62
2025
Q2
$651K Sell
1,700
-100
-6% -$36K 0.18% 157
2025
Q1
$622K Buy
1,800
+1,100
+157% +$354K 0.16% 158
2024
Q4
$210K Sell
700
-3,800
-84% -$1.33M 0.05% 247
2024
Q3
$1.83M Buy
4,500
+2,700
+150% +$989K 0.4% 40
2024
Q2
$578K Buy
+1,800
New +$585K 0.16% 88

Other funds holding HCA

Catalyst Funds Management's HCA Position: Q2 2026 in Review

Catalyst Funds Management increased its HCA Healthcare (HCA) stake by 270% in Q2 2026, buying an estimated $2.36M and bringing the position to 7,664 shares worth $2.99M. The position accounts for 0.17% of the portfolio, ranked #140.

Catalyst Funds Management first reported a position in HCA in Q2 2024 and has held it in 9 quarters since. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Catalyst Funds Management held 7,664 shares of HCA Healthcare worth $2.99M as of Q2 2026.
  • Catalyst Funds Management bought 5,590 HCA Healthcare shares in Q2 2026, an estimated $2.36M.
  • HCA Healthcare made up 0.17% of Catalyst Funds Management's portfolio in Q2 2026, its #140 holding.
  • Catalyst Funds Management first reported a position in HCA Healthcare in Q2 2024 and has held it in 9 quarters since.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.